Receive The Newest Study Notifications

 Syntrix Pharmaceuticals today announced that it has dosed the first patient in its Phase 1/2 clinical trial that will combine SX-682 with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy.  SX-682 is an oral dual inhibitor of  CXCR1 and CXCR2 (CXCR1/2) being...

High Point Clinical Trials Center announced a 3-year collaboration with ProSciento to join NASH PASS as a site partner, according to a press release. NASH PASS is Prosciento’s program designed to combine select qualified sites and a proprietary methodology to improve...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced results from an ongoing Phase 1b...

- Commenced patient enrollment in Phase 2 clinical trial of vopratelimab in combination with ipilimumab - - Preliminary efficacy and relationship to biomarker data expected in 2020 - CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc....

– Phase IIIb study met all primary and secondary endpoints with statistical significance and demonstrated that linaclotide improved the overall abdominal symptoms of bloating, pain and discomfort in adults with IBS-C – – Results further support the efficacy and safety...

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global venture capital company focused on investing and building breakthrough biotech companies, notes that its portfolio company Imara, Inc. ("Imara") has presented positive initial data from its ongoing Phase 2a clinical...

Torque, a clinical-stage immuno-oncology company developing Deep-Primed™ T Cell Therapeutics to direct immune power deep within the tumor microenvironment, announced today that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for Torque's...

The "Advanced Pharmacovigilance" conference has been added to ResearchAndMarkets.com's offering. This course will be of maximum benefit to those drug safety professionals who are working both in the clinical and post-marketing safety arena including QA for auditing...

BeiGene Co.,Ltd (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics Inc., a clinical-stage...

First global telemedicine solution, specifically designed to care for patients in clinical trials. Advancing eCOA with virtual visits, remote clinical care and screening. Globally connected research ecosystem in which every person in the world has the opportunity to...

HPCTC enters a multi-year partnership to establish a database enriched for subjects with NAFLD/NASH as a member of ProSciento's NASH PASS Site Network HIGH POINT, N.C., June 19, 2019 /PRNewswire/ -- High Point Clinical Trials Center, LLC, the largest independent...

Balixafortide is the most advanced and only CXCR4 antagonist in development in a pivotal Oncology global registration trial. Polyphor today announced the enrollment of the first patient in its FORTRESS clinical trial, the pivotal Phase III study evaluating...

By Rosamund Round, Victor Cheng, George Lee, Alberto Grignolo, Sy Pretorius at Pharmaceutical Executive Findings from a recent Economist Intelligence Unit (EIU) report1 indicate that the use of patient-centric clinical trials—that is, trials that are designed and...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform clinical-stage gene therapy company, today announces that patient dosing has commenced in the open-label, Phase 1 clinical trial of RP-A501, the Company’s adeno-associated...

Geneva, Switzerland and Boston, MA - June 19, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive...

Biocair has recently collaborated with University College London (UCL) to be the principal courier for a national clinical trial taking place in the United Kingdom.  The study, aimed at researching stroke prevention, treatment and management, involves a network of...

Nearly 50% of patients in national clinical trial saw significant improvement in skin condition that affected Michael Jackson, impacts millions worldwide A nationwide phase II clinical trial, coordinated out of Tufts Medical Center in Boston, has found that a topical...

The increasing sophistication of cancer treatments threatens to outpace the ability of health care providers to enroll patients in clinical trials to test those therapies. That's a key finding by researchers in UT Southwestern's new Department of Population and Data...

OnKure, Inc. and the University of Colorado Cancer Center today announced enrollment of the first patient in a first-in-human phase 1 clinical trial testing investigational anti-cancer agent OKI-179, a novel and Class-selective HDAC inhibitor, in patients with...

Top-Line Data Are Consistent with Previously Published Phase 1 Trial  PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for orphan diseases, today announced...